PROCEPT BioRobotics (PRCT) Share-based Compensation Growth (1y) (2021 - 2026)
PROCEPT BioRobotics (PRCT) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn | 12.94% |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | 59.09% |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | -30.44% |
| 10 | PROCEPT BioRobotics | 1.01 Bn | 768.73 Mn | 53.95 Mn | 29.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.32% |
| Dec 31, 2025 | 19.34% |
| Sep 30, 2025 | 70.21% |
| Jun 30, 2025 | 52.30% |
| Mar 31, 2025 | 61.57% |
| Dec 31, 2024 | 82.39% |
| Sep 30, 2024 | 59.84% |
| Jun 30, 2024 | 56.50% |
| Mar 31, 2024 | 67.99% |
| Dec 31, 2023 | 2,577.96% |
| Sep 30, 2023 | -71.12% |
| Jun 30, 2023 | 90.70% |
| Mar 31, 2023 | 139.95% |
| Dec 31, 2022 | 108.09% |
| Sep 30, 2022 | 1,893.51% |
| Jun 30, 2022 | 269.10% |
| Mar 31, 2022 | 138.77% |
| Dec 31, 2021 | -480.79% |